Approval · Notice of Compliance 14580 · 2013
RIZATRIPTAN: Notice of Compliance 14580
Issued July 23, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14580
- Date
- July 23, 2013
- Company
- Jubilant Life Sciences Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- 5-ht1 receptor agonist
- Canadian reference product
- MAXALT (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIZATRIPTAN | 02409399 | Approved |
| RIZATRIPTAN | 02409402 | Approved |
Medicinal ingredients
- RIZATRIPTAN BENZOATE 5 MG per TAB
- RIZATRIPTAN BENZOATE 10 MG per TAB